Alessandra Bulotta

1.2k total citations
47 papers, 695 citations indexed

About

Alessandra Bulotta is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Alessandra Bulotta has authored 47 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 29 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Alessandra Bulotta's work include Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (15 papers) and Lung Cancer Diagnosis and Treatment (10 papers). Alessandra Bulotta is often cited by papers focused on Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (15 papers) and Lung Cancer Diagnosis and Treatment (10 papers). Alessandra Bulotta collaborates with scholars based in Italy, United States and Japan. Alessandra Bulotta's co-authors include Vanesa Gregorc, Chiara Lazzari, Pierfrancesco Tassone, Teresa Calimeri, Luca Gianni, Aurora Mirabile, Michele Caraglia, Mariacarmela Santarpía, Rafael Rosell and Maria Grazia Viganò and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Alessandra Bulotta

40 papers receiving 686 citations

Peers

Alessandra Bulotta

ONCOL

PRM

IMMUN

Dana M. Roque United States

A. Lambiase Italy

Joshua Z. Drago United States

Miho Miyagawa Japan

Cristina Nieto‐Jiménez Spain

Mónica Musteanu Spain

Giuseppe Gullo Ireland

Andreas Varkaris United States

Devika Gajria United States

Dana M. Roque United States

Alessandra Bulotta

480 ×1.2

ONCOL

348 ×1.3

156 ×0.6

PRM

134 ×1.1

165 ×2.0

IMMUN

Citations per year, relative to Alessandra Bulotta Alessandra Bulotta (= 1×) peers Dana M. Roque

Countries citing papers authored by Alessandra Bulotta

Since Specialization

Citations

This map shows the geographic impact of Alessandra Bulotta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandra Bulotta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandra Bulotta more than expected).

Fields of papers citing papers by Alessandra Bulotta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandra Bulotta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandra Bulotta. The network helps show where Alessandra Bulotta may publish in the future.

Co-authorship network of co-authors of Alessandra Bulotta

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandra Bulotta. A scholar is included among the top collaborators of Alessandra Bulotta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandra Bulotta. Alessandra Bulotta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Servetto, Alberto, Biagio Ricciuti, Daniele Marinelli, et al.. (2025). Neoadjuvant vs perioperative chemo-immunotherapy according to pathological response in resectable non-small cell lung cancer: a reconstructed individual patient data meta-analysis. JNCI Journal of the National Cancer Institute. 117(11). 2388–2393. 1 indexed citations

Novellis, Pierluigi, Edoardo Bottoni, Piergiorgio Muriana, et al.. (2025). Robotic Surgery Is a Safe Treatment in Very Elderly Patients with Resectable Lung Cancer. Journal of Clinical Medicine. 14(12). 4314–4314.

Russano, Marco, Héctor Soto Parrà, Alessandra Bulotta, et al.. (2025). 70P: Amivantamab monotherapy in patients with pre-treated NSCLC with EGFR Exon 20 insertion mutations: Real-world data on efficacy and safety from the Italian biomarker ATLAS database. Journal of Thoracic Oncology. 20(3). S53–S54.

Citarella, Fabrizio, Kazuki Takada, Priscilla Cascetta, et al.. (2024). Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung). Journal of Translational Medicine. 22(1). 714–714. 3 indexed citations

Blaauwgeers, Hans, Birgit I. Lissenberg‐Witte, Andreas Schönau, et al.. (2024). Stereologic consequences of iatrogenic collapse: The morphology of adenocarcinoma in situ overlaps with invasive patterns. Proposal for a necessary modified classification of pulmonary adenocarcinomas. Lung Cancer. 197. 107987–107987.

Ceresoli, Giovanni Luca, Giulio Rossi, Francesco Agustoni, et al.. (2024). Management of patients with extensive small-cell lung cancer in the immunotherapy era: An Italian consensus through a Delphi approach. Critical Reviews in Oncology/Hematology. 199. 104247–104247. 1 indexed citations

Colonese, Francesca, Alessandra Bulotta, Carlo Genova, et al.. (2024). Immunotherapy in Non-Small-Cell Lung Cancer: A Modified Delphi Survey Consensus on First Line Treatment, Special Populations and Rechallenge. Biomedicines. 12(12). 2742–2742.

Pecciarini, Lorenza, Emanuela Brunetto, Greta Grassini, et al.. (2023). Gene Fusion Detection in NSCLC Routine Clinical Practice: Targeted-NGS or FISH?. Cells. 12(8). 1135–1135. 12 indexed citations

Cangi, Maria Giulia, Gabriele Bucci, Giorgia Foggetti, et al.. (2023). 55P EGFR variant allele frequency (VAF) impacts on metastatic NSCLC patients outcome during first-line osimertinib. ESMO Open. 8(1). 101865–101865.

10.

Lazzari, Chiara, Mona‐Rita Yacoub, Corrado Campochiaro, et al.. (2023). Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies. Frontiers in Oncology. 13. 1079034–1079034. 1 indexed citations

11.

Campochiaro, Corrado, Nicola Farina, Alessandro Tomelleri, et al.. (2022). Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors. European Journal of Internal Medicine. 103. 95–99. 8 indexed citations

12.

Gagliardi, Filippo, Silvia Snider, Lina Raffaella Barzaghi, et al.. (2021). Role of stereotactic radiosurgery for the treatment of brain metastasis in the era of immunotherapy: A systematic review on current evidences and predicting factors. Critical Reviews in Oncology/Hematology. 165. 103431–103431. 13 indexed citations

13.

Campochiaro, Corrado, Nicola Farina, Alessandro Tomelleri, et al.. (2021). Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series. European Journal of Internal Medicine. 93. 87–94. 55 indexed citations

14.

Paolino, Giovanni, Riccardo Pampena, Caterina Longo, et al.. (2020). Clinicopathological and dermoscopic features of amelanotic and hypomelanotic melanoma: a retrospective multicentric study. International Journal of Dermatology. 59(11). 1371–1380. 8 indexed citations

15.

Mirabile, Aurora, Licia Rivoltini, Elena Daveri, et al.. (2020). Metabolism and Immune Modulation in Patients with Solid Tumors: Systematic Review of Preclinical and Clinical Evidence. Cancers. 12(5). 1153–1153. 4 indexed citations

16.

Paolino, Giovanni, Vanesa Gregorc, Santo Raffaele Mercuri, et al.. (2020). Immunohistochemical Evaluation and Clinicopathological Correlation of Mer and Axl Tyrosine Kinase TAM Receptors in Cutaneous Melanoma. Dermatology Practical & Conceptual. 10(2). e2020029–e2020029. 2 indexed citations

17.

Lazzari, Chiara, Greta Grassini, Emanuela Brunetto, et al.. (2019). Identification and monitoring of somatic mutations in circulating cell-free tumor DNA in lung cancer patients. Lung Cancer. 134. 225–232. 13 indexed citations

18.

Lazzari, Chiara, Anna Spreafico, Angela Bachi, et al.. (2011). Changes in Plasma Mass-Spectral Profile in Course of Treatment of Non-small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. Journal of Thoracic Oncology. 7(1). 40–48. 33 indexed citations

19.

Tassone, Pierfrancesco, Marco Rossi, Teresa Calimeri, et al.. (2009). Challenging the Current Approaches to Multiple Myeloma-Related Bone Disease: From Bisphosphonates to Target Therapy. Current Cancer Drug Targets. 9(7). 854–870. 19 indexed citations

20.

Neri, Paola, Pierosandro Tagliaferri, Maria Teresa Di Martino, et al.. (2008). In vivo anti‐myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor. British Journal of Haematology. 143(4). 520–531. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact